MOH — authorised 31 December 1993
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
MOH authorised Lescol on 31 December 1993
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 31 December 1993.
NOVARTIS holds the UAE marketing authorisation.